Deutsche Bank AG Reiterates “CHF 254” Price Target for Roche Holding Ltd. (ROG)
Roche Holding Ltd. (VTX:ROG) has been given a CHF 254 target price by Deutsche Bank AG in a research note issued to investors on Friday. The brokerage presently has a “neutral” rating on the healthcare company’s stock.
Several other analysts have also recently issued reports on the stock. HSBC Holdings plc set a CHF 203 price target on shares of Roche Holding and gave the stock a “sell” rating in a research report on Friday. Sanford C. Bernstein set a CHF 284 target price on shares of Roche Holding and gave the stock a “buy” rating in a research note on Tuesday, July 18th. Goldman Sachs Group, Inc. (The) set a CHF 325 target price on shares of Roche Holding and gave the stock a “buy” rating in a research note on Monday, September 11th. J P Morgan Chase & Co reiterated a “buy” rating on shares of Roche Holding in a research note on Tuesday, June 27th. Finally, Baader Bank set a CHF 231 price target on shares of Roche Holding and gave the company a “neutral” rating in a research note on Tuesday, September 12th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of CHF 263.81.
Shares of Roche Holding (VTX:ROG) opened at 234.40 on Friday. Roche Holding has a 12-month low of CHK 218.30 and a 12-month high of CHK 273.00. The stock has a 50 day moving average of CHK 245.36 and a 200 day moving average of CHK 250.97. The company has a market cap of CHK 200.00 billion and a price-to-earnings ratio of 20.81.
TRADEMARK VIOLATION WARNING: This piece of content was originally posted by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/10/20/deutsche-bank-ag-reiterates-chf-254-price-target-for-roche-holding-ltd-rog.html.
About Roche Holding
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.